Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea

PHASE3CompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

September 30, 2012

Study Completion Date

February 28, 2013

Conditions
Japanese Encephalitis
Interventions
BIOLOGICAL

JE vaccine

3 times, IM

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

collaborator

Gachon University Gil Medical Center

OTHER

collaborator

Inha University Hospital

OTHER

collaborator

Inje University

OTHER

collaborator

Korea Cancer Center Hospital

OTHER

collaborator

Samsung Medical Center

OTHER

collaborator

The Catholic University of Korea

OTHER

collaborator

Ewha Womans University

OTHER

collaborator

Wonju Severance Christian Hospital

OTHER

collaborator

Kyunghee University Medical Center

OTHER

lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY